Sexual Medicine Society of North America, Inc.

Scientific Program

Thursday, October 24, 2019
Morning
07:55 a.m. - 09:50 a.m.
Location: Broadway Ballroom A-B
APN/PA Session - Part 1
Moderator: Jeffrey Albaugh, PhD, APRN, CUCNS
07:55 a.m. - 08:00 a.m.
Welcome
Speaker: Jeffrey Albaugh, PhD, APRN, CUCNS
08:00 a.m. - 08:20 a.m.
Thinking Outside the Box About What is Inside the Box: Barriers and Facilitators for Sexual Aids
Speaker: Christine Zarowski, BSN, RN
08:20 a.m. - 08:50 a.m.
Mental Health Issues & Sexual Dysfunction in Veterans
Speakers: Penny Jensen, DNP, FNP-C, FAAN, FAANP & Kenneth Mitchell, MPAS, PA-C
08:50 a.m. - 09:50 a.m.
Pharmacology - Multiple Topics in Sexual Health
Speakers: Cynthia Bednarchik, DNP(c), MSN, APRN, FNP-BC & Mary Hitt, MSN, FNP-BC
08:00 a.m. - 10:10 a.m.
Location: Broadway Ballroom F
Basic Science Session - Multi-omics Approach to Sexual Medicine - Part 1
Moderators: Bridget Koontz, MD & Carol Podlasek, PhD
08:00 a.m. - 08:05 a.m.
Introduction
Speaker: Kelvin Davies, BSc, MSc, PhD
08:05 a.m. - 08:30 a.m.
A Historical Perspective From One of the First Applications of Omics/Microarray Technology to Sexual Medicine
Speaker: Nestor Gonzalez-Cadavid, PhD
08:30 a.m. - 08:55 a.m.
Introduction to the Power of Omics Studies
Speaker: Benjamin Christensen, PhD
08:55 a.m. - 09:20 a.m.
Gene Array Data Discoveries in ED
Speaker: Trinity Bivalacqua, MD, PhD
09:20 a.m. - 09:45 a.m.
Global Gene Expression Analysis Identifying a Role of Opiorphin in Erectile Function
Speaker: Kelvin Davies, BSc, MSc, PhD
09:45 a.m. - 10:10 a.m.
How to Apply OMICs Discoveries: A Novel Phenotypic Approach for Fibrotic Diseases
Speaker: Selim Cellek, MD, PhD
08:00 a.m. - 10:15 a.m.
Location: Broadway Ballroom C-D
SMSNA/CSA Session - Part 1
Moderators: Hui Jiang, MD & Run Wang, MD, FACS
08:00 a.m. - 08:05 a.m.
Welcome
Speakers: Hui Jiang, MD; Hossein Sadeghi-Nejad, MD, FACS & Run Wang, MD, FACS
08:05 a.m. - 08:25 a.m.
Opportunities and Challenges for the Development of Chinese Sexual Medicine
Speaker: Hui Jiang, MD
08:25 a.m. - 08:40 a.m.
A New Classification of the Premature Ejaculation Based on the Neuroelectrophysiology
Speaker: Yutian Dai, MD, PhD
08:40 a.m. - 08:55 a.m.
Low-intensity Extracorporeal Shock Wave for ED and Acute Phase of Peyronies Disease
Speaker: Mujun Lu, MD, PhD
08:55 a.m. - 09:10 a.m.
The Clinical Research on the Effectiveness of P450arom in Late Onset Hypogonadism
Speaker: Jingqi Wang, MD
09:10 a.m. - 09:25 a.m.
Molecular Mechanism of Androgen on Erectile Function
Speaker: Rui Jiang, MD, PhD
09:25 a.m. - 09:40 a.m.
The Failure of Sexual Arousal Among Newly Married Women: Clinical Observation and Significances
Speaker: Jiao Wu, MD
09:40 a.m. - 09:50 a.m.
Adolescent Sexual Reproductive Health: My Innovation and Practice
Speaker: Youwei Le, MD
09:50 a.m. - 10:00 a.m.
VED Therapy for ED after Cavernous Nerve Injury: Molecular Mechanism
Speaker: Baibing Yang, MD
10:00 a.m. - 10:15 a.m.
Innovations of Sexual medicine in China
Speaker: Tao Jiang, MD
08:30 a.m. - 10:00 a.m.
Location: Cumberland 1
Instructional Course - Hypogonadism
Moderator: Mohit Khera, MD
08:30 a.m. - 08:50 a.m.
Diagnosis and Management
Speaker: Wayne Hellstrom, MD
08:50 a.m. - 09:10 a.m.
Understanding Prostate and Cardiovascular Risk
Speaker: Abraham Morgentaler, MD
09:10 a.m. - 09:30 a.m.
AUA Testosterone Guidelines
Speaker: John Mulhall, MD
09:30 a.m. - 09:50 a.m.
Alternative Testosterone Therapies
Speaker: Mohit Khera, MD
09:50 a.m. - 10:00 a.m.
Q&A
08:30 a.m. - 10:00 a.m.
Location: Cumberland 2
Instructional Course - Female Sexual Dysfunction - Genital Dysesthesia Disorders in Women
Moderator: Irwin Goldstein, MD
08:30 a.m. - 08:35 a.m.
Introduction
Speaker: Irwin Goldstein, MD
08:35 a.m. - 08:45 a.m.
ISSWSH Definitions of Various Genital Dysesthesias - Hyperfunction Including PGAD, Pain - Hypofunction including FSAD, FOD
Speaker: Rachel Rubin, MD
08:45 a.m. - 09:05 a.m.
Urology Testing to Determine Etiology of Genital Dysesthesia (Irwin Goldstein) - Hormone Testing (Rachel Rubin) - Neurogenital Testing (Irwin Goldstein)
Speakers: Irwin Goldstein, MD & Rachel Rubin, MD
09:05 a.m. - 09:20 a.m.
Referral Testing to Determine Management - MRI - TFESI - Spinal Column Stimulator
Speaker: Choll Kim, MD, PhD
09:20 a.m. - 09:40 a.m.
Treatment: By the Urologist (Rachel Rubin) - By the Pain Management Specialist (Choll Kim) - By the Spine Surgeon (Choll Kim)
Speakers: Choll Kim, MD, PhD & Rachel Rubin, MD
09:40 a.m. - 09:50 a.m.
Post-treatment Testing by the Urologist to Determine Efficacy - Hyperfunction Including PGAD, Pain - Hypofunction Including FSAD, FOD
Speaker: Irwin Goldstein, MD
09:50 a.m. - 10:00 a.m.
Q&A
10:00 a.m. - 10:30 a.m.
Location: Broadway Ballroom Foyer
Coffee Break
10:00 a.m. - 12:00 p.m.
Location: Broadway Ballroom A-B
APN/PA Session - Part 2
Moderator: Jeffrey Albaugh, PhD, APRN, CUCNS
10:00 a.m. - 10:30 a.m.
Panel - Coding for Sexual Medicine
Speakers: Cynthia Bednarchik, DNP(c), MSN, APRN, FNP-BC; John Dodge, PA-C, MPAS; Mary Hitt, MSN, FNP-BC; Richard Jones, MS, PA-C & Kenneth Mitchell, MPAS, PA-C
10:30 a.m. - 11:00 a.m.
Testosterone Replacement
Speakers: John Dodge, PA-C, MPAS & Mohit Khera, MD
11:00 a.m. - 11:30 a.m.
Sexual Counselling/Therapy - or Alternative Sexual Practices
Speakers: Brooke Faught, DNP, WHNP-BC, NCMP & Claire Postl, MA, LPCC
11:30 a.m. - 12:00 p.m.
Running an ED Penile Injection Clinic
Speaker: Richard Jones, MS, PA-C
10:30 a.m. - 11:30 a.m.
Location: Broadway Ballroom F
Basic Science Session - Multi-omics Approach to Sexual Medicine - Part 2
Moderators: Johanna Hannan, PhD & Alexander Pastuszak, MD, PhD
10:30 a.m. - 11:00 a.m.
Keynote Speaker- GWAS Study to Identify Factors Associated with Erectile Dysfunction
Speaker: Eric Jorgenson, PhD
11:00 a.m. - 11:30 a.m.
Keynote Speaker- Proteomics and Cardiac Fibrosis
Speaker: Merry Lindsey, PhD
10:30 a.m. - 12:00 p.m.
Location: Cumberland 1
Instructional Course - Peyronie's Disease
Moderator: Laurence Levine, MD
10:30 a.m. - 10:55 a.m.
Pathophysiology and Patient Evaluation
Speaker: Matthew Ziegelmann, MD
10:55 a.m. - 11:25 a.m.
Non-surgical Treatment
Speaker: Petar Bajic, MD
11:25 a.m. - 12:00 p.m.
Surgical Treatment
Speaker: Laurence Levine, MD
10:30 a.m. - 12:00 p.m.
Location: Cumberland 2
Instructional Course - Gay and Transgender Issues in Sexual Medicine
Moderator: Alan Shindel, MD
Discussing Sexual Healthcare Needs of Transgender Individuals, Particularly Transgender Women
Speaker: Maurice Garcia, MD, MAS
Meeting the Sexual Healthcare Needs of Women Who Have Sex with Women
Speaker: Tami Rowen, MD, MS, FACOG
Meeting the Sexual Healthcare Needs of Men Who Have Sex with Men
Speaker: Alan Shindel, MD
10:30 a.m. - 12:00 p.m.
Location: Broadway Ballroom C-D
SMSNA/CSA Session - Part 2
Moderators: Yutian Dai, MD, PhD & Haocheng Lin, MD, PhD
10:30 a.m. - 10:45 a.m.
The Role of PHF7 in Male Infertility
Speaker: Haocheng Lin, MD, PhD
10:45 a.m. - 11:00 a.m.
Microsurgical Subinguinal Varicocelectomy: Learning Curve Experiences and Follow-ups
Speaker: Songxi Tang, MD
11:00 a.m. - 11:15 a.m.
Genetic Testing and Cases of Male Infertility and Recurrent Pregnancy Loss
Speaker: Zhipeng Xu, MD
11:15 a.m. - 11:30 a.m.
Scrotoscopic Tunica Vaginalis Excision for Hydrocele
Speaker: Xinjun Su, MD
11:30 a.m. - 11:45 a.m.
Clinical Significance of Several Specific Forms of Teratozoospermia
Speaker: Liang Shi, MD
11:45 a.m. - 11:55 a.m.
A Combination of Semen Cuscutae and Fructus Lycii Improves Testicular Cell Proliferation and Inhibits Their Apoptosis in Rats with Spermatogenic Dysfunction by Regulating the SCF/c-kit--PI3K--Bcl-2 Pathway
Speaker: Yutian Zhu, PhD
11:55 a.m. - 12:00 p.m.
Closing Remarks
Speakers: Hui Jiang, MD & Run Wang, MD, FACS
11:30 a.m. - 12:00 p.m.
Location: Broadway Ballroom F
Basic Science Symposium - Multi-omics Approach to Sexual Medicine - 3 Minute Thesis Competition for Trainees
Moderator: Johanna Hannan, PhD
Afternoon
12:00 p.m. - 01:00 p.m.
Location: Broadway Ballroom E
SMSNA Committee Fair
12:00 p.m. - 01:00 p.m.
Location: Broadway Ballroom C-D
APN/PA Networking Lunch
12:00 p.m. - 01:00 p.m.
Location: Broadway Ballroom A-B
Basic Science: Lunch with the Experts
01:00 p.m. - 01:10 p.m.
Location: Broadway Ballroom F
Welcome / CME Announcement
Speakers: Alexander Pastuszak, MD, PhD & Hossein Sadeghi-Nejad, MD, FACS
01:10 p.m. - 02:00 p.m.
Location: Broadway Ballroom F
Keynote Lecture - Living the Dream: Tracy Byrd
Living the Dream
Speaker: Tracy Byrd
02:00 p.m. - 03:30 p.m.
Location: Broadway Ballroom F
Mental Health
Moderators: Christian Nelson, PhD & Daniela Wittmann, PhD, LMSW
02:00 p.m. - 02:12 p.m.
Pelvic Pain - Assessment and Treatment
Speaker: James Pfaus, PhD
02:12 p.m. - 02:24 p.m.
Acceptance and Commitment Therapy - Improving Adherence to the Use of Erectile Aids
Speaker: Christian Nelson, PhD
02:24 p.m. - 02:36 p.m.
ED and Masculinity
Speaker: Andrew Matthew, PhD
02:36 p.m. - 02:46 p.m.
Taking Matters Into Their Own Hands: Men Seeking Pornography Addiction Advice From a Nontraditional Online Therapy Source (#001)
Speaker: Bobby Vanmali
02:46 p.m. - 02:56 p.m.
Feasibility, Acceptability, And Satisfaction With A Web-Based Intervention Promoting Sexual Recovery For Couples Coping with Prostate Cancer (#002)
Speaker: Akanksha Mehta
02:56 p.m. - 03:08 p.m.
High fidelity: Restoring Sexuality After an Affair
Speaker: Kathryn Hall, PhD
03:08 p.m. - 03:30 p.m.
Panel discussion - Combining Urology and Psychiatry: Teaching a Biopsychosocial Approach to Sexual Problems to Medical Students at Vanderbilt University
Speakers: Carol Milam, MD & Douglas Milam, MD
02:00 p.m. - 03:30 p.m.
Location: Broadway Ballroom A-B
Erectile Dysfunction Medical / Surgical - Moderated Posters
Moderators: Brittani Barrett-Harlow, MD & Alexander Tatem, MD
02:15 p.m. - 02:20 p.m.
Immune Deficient Status Does Not Increase Inflatable Penile Prosthesis Reoperation Rates (#101)
Speaker: Christopher Gaffney
02:20 p.m. - 02:25 p.m.
Adipose-derived Stem Cells (ASCs) Combined with Control-released DF-PEG/GCS Hydrogel Scaffold Restore the Erectile Function in a Diabetes Rat Model (#102)
Speaker: Mujun Lu
02:25 p.m. - 02:30 p.m.
Prospective Analysis of Cultures from the Furlow Insertion Tool: A Possible Etiology for Penile Prosthesis Infections (#103)
Speaker: Faysal Yafi, MD, FRCSC
02:30 p.m. - 02:35 p.m.
Optimization of handheld Wand to Activate a Shape Memory Penile Prosthesis (#104)
Speaker: Rebecca Gerber
02:35 p.m. - 02:40 p.m.
Impact of Antimicrobial Dipping Solutions on Post-Operative Infection Rates in Diabetic Patients Undergoing Primary Insertion of a Coloplast Titan Inflatable Penile Prosthesis (#105)
Speaker: Mohamad M. Osman
02:40 p.m. - 02:45 p.m.
Immediate Preoperative Blood Glucose and Hemoglobin A1c Levels are not Predictive of Post-Operative Infections in Diabetic Men Undergoing Penile Prosthesis Placement (#106)
Speaker: Mohamad M. Osman
02:45 p.m. - 02:50 p.m.
Initial Experience with the Boston Scientific Tactra Semi-Rigid Penile Prosthesis: A Multi-Institutional Case Series (#107)
Speaker: Samantha Nealon
02:50 p.m. - 02:55 p.m.
A Comprehensive Assessment of Current Penile Prosthesis Reimbursement Guidelines for Insurance Plans Nationwide (#108)
Speaker: Kevin Krughoff
02:55 p.m. - 03:00 p.m.
Predictors of Rapid Disease Progression from Initial Diagnosis of Erectile Dysfunction to Surgical Intervention (#109)
Speaker: Hossein Mirheydar
03:00 p.m. - 03:05 p.m.
The Role of Traditional Urology Office Visits for Erectile Dysfunction in Young Men in the Era of Direct-to-Consumer Internet Platforms (#110)
Speaker: Robert Shahinyan
03:05 p.m. - 03:10 p.m.
Your Penis Wants you to Quit: ED Knowledge and Smoking Cessation Motivation in an Urban Urology Clinic (#111)
Speaker: Mathew Q.I. Fakhoury
03:10 p.m. - 03:15 p.m.
Vibro-elastography: A Novel, Non-invasive Tool for Evaluating Penile Fibrosis (#112)
Speaker: Matthew Houlihan
03:15 p.m. - 03:20 p.m.
An Evidence-Based Analysis of Ingredients in Popular Supplements for Erectile Dysfunction (#113)
Speaker: Manish Kuchakulla
03:20 p.m. - 03:25 p.m.
Ultrasound Doppler Measurements of Penile Blood Flow as a Predictor of Clinical Efficacy (#114)
Speaker: Tim Holland
02:00 p.m. - 03:30 p.m.
Location: Broadway Ballroom C-D
Miscellaneous / Epidemiology - Moderated Posters
Moderators: Hwancheol Son, MD, PhD & Matthew Ziegelmann, MD
02:20 p.m. - 02:25 p.m.
Interstitial Cystitis/Bladder Pain Syndrome as Referred Pain from Injured T12/L1 Nerves: Symptomatic Improvement with Resection of Ilioinguinal and Iliohypogastric Nerves (#116)
Speaker: Kelly Harris
02:25 p.m. - 02:30 p.m.
Effectiveness of Physician-Tailored Medical Care on Patient Understanding and Doctor-Patient Trust (#117)
Speaker: Lawrence Jenkins, MD, MBA
02:30 p.m. - 02:35 p.m.
Effect of Limiting Narcotic Prescription on Pain Control Following Ambulatory Scrotal Surgery (#118)
Speaker: Libert Ramos
02:35 p.m. - 02:40 p.m.
Analysis of the Cost of Inflatable Penile Prosthesis for Self-Pay Patients (#119)
Speaker: Alyssa Yee
02:40 p.m. - 02:45 p.m.
Adherence to an Organic Diet is Protective Against Hypogonadism and Erectile Dysfunction (#120)
Speaker: Farouk M. El-Khatib
02:45 p.m. - 02:50 p.m.
Relationship between Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Erectile dysfunction (#121)
Speaker: Jun Ho Lee
02:50 p.m. - 02:55 p.m.
Microsurgical Varicocelectomy in Men with Nonobstructive Azoospermia: A Means for Sperm Recovery (#122)
Speaker: Jacob Brems
02:55 p.m. - 03:00 p.m.
A Thematic Analysis of Sexual Function Conversations on a Spinal Cord Injury Social Media Platform (#123)
Speaker: Kyle Latack
03:00 p.m. - 03:05 p.m.
The Persistent Effects of 5α-reductase Inhibitors Used in the Treatment of Androgenic Alopecia on Men's Health (#124)
Speaker: Jorge Rivera Mirabal
03:05 p.m. - 03:10 p.m.
Regional Variation in Penile Prosthesis Utilization among Medicare Patients Diagnosed with Erectile Dysfunction (#125)
Speaker: Michael Rezaee
03:10 p.m. - 03:15 p.m.
Real-World Assessment of the Impact of Erectile Dysfunction on Sexual Planning Behavior and Health- and Treatment-Related Outcomes Among Men in 8 Countries (#126)
Speaker: Irwin Goldstein, MD
03:15 p.m. - 03:20 p.m.
Misuse of Testosterone Replacement Therapy in Infertile Couples and Influence on the Infertility Treatment Program (#127)
Speaker: Seung-Hun Song
03:20 p.m. - 03:25 p.m.
Interest in Erectile Dysfunction Treatment Is Associated with National Economic Indicators: a Google Trends analysis (#128)
Speaker: Anuj Desai
03:25 p.m. - 03:30 p.m.
Emerging Data Regarding Online Search Behaviors for Common Sexual Medicine Conditions (#129)
Speaker: Amanda Swanton
03:30 p.m. - 04:00 p.m.
Location: Broadway Ballroom G-K
Coffee Break
03:35 p.m. - 04:00 p.m.
Location: Broadway Ballroom Foyer - E-poster Station 1
E-poster Session 1 - Erectile Dysfunction Surgical 1
Moderator: Jason Akerman, MD
03:35 p.m. - 03:38 p.m.
Outcomes of Modified Glans Hypermobility Correction at Time of Initial IPP (#301)
Speaker: Nikki Dodge
03:38 p.m. - 03:41 p.m.
Outcomes Related to Penile Prosthesis Reservoir Removal: A Multi-institutional Experience (#302)
Speaker: Jonathan Clavell, MD
03:41 p.m. - 03:44 p.m.
Modeling the Biomechanical Behavior of the Corpora Cavernosa as it Relates to Prosthetics (#303)
Speaker: Brian Le
03:44 p.m. - 03:47 p.m.
Penile Implant Infection: Experience with Expanded Salvage Criteria and a Shortened Course of Post-Operative Antibiotics (#304)
Speaker: Jason Chandrapal
03:47 p.m. - 03:50 p.m.
Revision Surgeries as a Risk Factor for Postoperative Complications in IPP Placement. (#305)
Speaker: Jake Miller
03:50 p.m. - 03:53 p.m.
Comorbid Predictors for Corporal Body Fibrosis in Patients Undergoing Placement of an Inflatable Penile Prosthesis (#306)
Speaker: Alexander Sherman
03:53 p.m. - 03:56 p.m.
Rising to the Occasion: Utilizing Penile Prosthetic Surgery to Motivate Patients' Diabetes Control (#307)
Speaker: Brittani Barrett-Harlow, MD
03:56 p.m. - 03:59 p.m.
Minimizing Candida Infections: Adding Antifungal Agents to the Implant Dip (#308)
Speaker: Matthew Brennan
03:35 p.m. - 04:00 p.m.
Location: Broadway Ballroom Foyer - E-poster Station 2
E-poster Session 2 - Basic Science / Androgens / Cancer Survivorship
Moderator: Petar Bajic, MD
03:35 p.m. - 03:38 p.m.
Radiation-induced Schwann Cell Dedifferentiation Leads to Opposing Growth in Whole Ganglia vs Dissociated Cultured Pelvic Neurons (#309)
Speaker: Joshua Randolph
03:38 p.m. - 03:41 p.m.
Does Improvement in Endothelial Function affect Erectile Function following Stem Cell Therapy in Men with Cardiomyopathy? (#310)
Speaker: Russell Saltzman
03:41 p.m. - 03:44 p.m.
Non-alcoholic Fatty Liver Disease and Erectile Dysfunction in S-nitrosoglutathione Reductase (GSNOR) Deficiency (#311)
Speaker: Dorota Hawksworth
03:44 p.m. - 03:47 p.m.
Endogenous Vasoactive Peptides in the Control of Penile Erectile Tissue: Is there a Role of Arginine-Vasopressin (AVP)? (#312)
Speaker: Stefan Ückert
03:47 p.m. - 03:50 p.m.
Improvement of Urinary Function Improves in Hypogonadal Men Receiving Long-term Treatment with Testosterone Compared to a Hypogonadal Control Group: 7116 Patient-years of Clinical Experience (#314)
Speaker: Ahmad Haider
03:50 p.m. - 03:53 p.m.
The Impact of Educational Package on Nursing Students' Knowledge Towards Fertility Preservation, A Quasi-experimental Study (#315)
Speaker: Kajal Khodamoradi
03:53 p.m. - 03:56 p.m.
Paradigm Shifting Beneficial Effects of TLANDO (Oral Testosterone) on Liver (#316)
Speaker: Mahesh Patel
03:35 p.m. - 04:00 p.m.
Location: Broadway Ballroom Foyer - E-poster Station 3
E-poster Session 3 - Erectile Dysfunction Medical 1
Moderator: Jonathan Beilan, MD
03:35 p.m. - 03:38 p.m.
Follow-up Assessment on the Treatment of Erectile Dysfunction With Bimix Gel (#317)
Speaker: Daniel Martinez
03:38 p.m. - 03:41 p.m.
Retrospective Review of Improvement of Erectile Function after Low Intensity Shockwave Treatment with Urogold 100™ (#318)
Speaker: Jessica Yih, MD
03:41 p.m. - 03:44 p.m.
Predicting Intracavernosal Injection Therapy Failure by Evaluating Medical Risk Factors in Men with Erectile Dysfunction (#319)
Speaker: Steven Lomax
03:44 p.m. - 03:47 p.m.
Male Pelvic Floor Dysfunction: The Great Masquerader (#320)
Speaker: Scott Geiger
03:47 p.m. - 03:50 p.m.
Comparison of Low Intensity Shockwave for Erectile Dysfunction Using Electrohydraulic vs Radial Shockwave Generators (#321)
Speaker: Daniel Shoskes
03:50 p.m. - 03:53 p.m.
Two-years Follow-up: Penile Rehabilitation Program with Early” Low-dose Tadalafil after Nerve-sparing Radical Prostatectomy - Increased “Early” Nocturnal Penile Tumescence 8 Days After Nerve-sparing Radical Prostatectomy is Correlated with Further Erectile Function Recovery 24 Months after Prostatectomy (#322)
Speaker: Andreas Bannowsky
03:53 p.m. - 03:56 p.m.
Phase II, Open-label, Randomized, Clinical Trial Evaluating Two Schedules of Low-intensity Shockwave Therapy for the Treatment of Erectile Dysfunction (#323)
Speaker: Manuel Molina
03:56 p.m. - 03:59 p.m.
Shock Wave Erectile Enhancement Trial (SWEET) Study: A 41 Site Study on the Use of Shock Wave Therapy for the Treatment of Erectile Dysfunction (#324)
Speaker: Judson Brandeis
04:00 p.m. - 05:30 p.m.
Location: Broadway Ballroom F
Videos in Sexual Medicine
Moderators: Hui Jiang, MD & Steven Wilson, MD
04:00 p.m. - 04:12 p.m.
Vaginoplasty
Speaker: Daniel Dugi, MD
04:12 p.m. - 04:24 p.m.
Phalloplasty
Speaker: Maurice Garcia, MD, MAS
04:24 p.m. - 04:36 p.m.
IPP Revision - My Hardest Cases
Speaker: Rafael Carrion, MD
04:36 p.m. - 04:48 p.m.
IPP Placement in Transgender Men
Speaker: Mang Chen, MD
04:48 p.m. - 05:18 p.m.
Debate: Severe ED with 90 Degree Curvature, Hourglass, and Penile Shortening
Speakers: Brian Christine, MD; Tobias Kohler, MD, MPH; Robert Valenzuela, MD & Run Wang, MD, FACS
05:18 p.m. - 05:30 p.m.
Q&A
04:00 p.m. - 05:30 p.m.
Location: Broadway Ballroom C-D
Female Sexual Dysfunction - Medical & Surgical Session 1
Moderators: Irwin Goldstein, MD & Ashley Winter, MD
04:00 p.m. - 04:12 p.m.
FSD Consensus Papers - Identification of Sexual Health Concerns in Women
Speaker: Sharon Parish, MD, NCMP
04:12 p.m. - 04:24 p.m.
FSD Consensus Papers - Androgens in the Treatment of GSM
Speaker: James Simon, MD, CCD, NCMP, IF, FACOG
04:24 p.m. - 04:36 p.m.
FSD Consensus Papers - HSDD Process of Care
Speaker: Erika Kelley, PhD
04:36 p.m. - 04:46 p.m.
Two-Arm, Prospective, Open-Label, Pilot Study of Flibanserin versus Flibanserin and Sex Therapy in Pre- and Postmenopausal Women with HSDD (#003)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE
04:46 p.m. - 04:56 p.m.
Neurogenic Persistent Genital Arousal Disorder (PGAD) Secondary to Radiculopathy of Sacral Spinal Nerve Roots (SSNR): Treatment Outcomes Following Minimally Invasive Spine Surgery (MISS) (#004)
Speaker: Choll Kim, MD, PhD
04:56 p.m. - 05:06 p.m.
HSDD, Flibanserin, and Eye Dynamics: A Double-blind Randomized Placebo-controlled Clinical Trial (#005)
Speaker: Temisan Blagogee
05:06 p.m. - 05:30 p.m.
Debate: Treatment of HSDD: Daily vs. On Demand
Speakers: Brooke Faught, DNP, WHNP-BC, NCMP & Sue Goldstein, BA, CCRC, AASECT-CSE
04:00 p.m. - 05:30 p.m.
Location: Broadway Ballroom A-B
So You Want to be Rich and Successful? (ISSM Session)
Moderator: Gerald Brock, MD
04:00 p.m. - 04:15 p.m.
What is Rich and Why You'd Want to Become Rich and Successful
Speaker: Gerald Brock, MD
04:15 p.m. - 04:30 p.m.
Social Entrepreneurship: The Richness of Giving Back
Speaker: Arthur Burnett, MD
04:30 p.m. - 04:45 p.m.
Digital and Social Media Marketing for Direct to Patient Referrals
Speaker: Andrew Kramer, MD
04:45 p.m. - 05:00 p.m.
How to Optimize your Portfolio at Various Stages of Your Career
Speaker: Ron Paprocki, JD, CFP, CHBC
05:00 p.m. - 05:15 p.m.
Making an International Society Successful
Speaker: Luiz Otavio Torres, MD
05:15 p.m. - 05:20 p.m.
WMSM 2020 Announcement
Speaker: Yoshikazu Sato, MD
05:20 p.m. - 05:30 p.m.
Q&A
05:30 p.m. - 06:30 p.m.
Location: Broadway Ballroom F
Opening Ceremony
Evening
06:30 p.m. - 08:00 p.m.
Location: Broadway Ballroom G-K
Welcome Reception
Friday, October 25, 2019
Morning
07:00 a.m. - 08:00 a.m.
Location: Broadway Ballroom E
SMSNA Breakfast Symposium Supported by Industry
08:00 a.m. - 10:00 a.m.
Location: Broadway Ballroom F
Androgens
Moderators: Mohit Khera, MD & Alexander Pastuszak, MD, PhD
08:00 a.m. - 08:18 a.m.
DM and Hypogonadism: History and Clinical Implications (non-CME)
Speaker: Farid Saad, DVM, PhD
08:18 a.m. - 08:36 a.m.
Of Mice and Insulin: Basic Research Defining the Link Between DM and Hypogonadism
Speaker: Michael DiSanto, PhD
08:36 a.m. - 08:54 a.m.
Adult Onset Hypogonadism: Implications for Care of the Aging Male Population
Speaker: Mohit Khera, MD
08:54 a.m. - 09:04 a.m.
Using Serum 17-hydroxyprogesterone to Evaluate Changes in Intratesticular Testosterone Among Men Receiving Therapies That Alter Serum Testosterone (#006)
Speaker: Thiago Lima
09:04 a.m. - 09:14 a.m.
Trends in Serum Testosterone Levels Among Adolescent and Young Adult Men in the United States (#007)
Speaker: Premal Patel
09:14 a.m. - 09:24 a.m.
LPCN 1144 Reduces Liver Fat in Men with Fatty Liver (#008)
Speaker: Irwin Goldstein, MD
09:24 a.m. - 09:49 a.m.
Panel Discussion - The Future of Testosterone Therapy
Speakers: Mohit Khera, MD; Abraham Morgentaler, MD & Farid Saad, DVM, PhD
09:49 a.m. - 10:00 a.m.
Q&A
10:00 a.m. - 10:30 a.m.
Location: Broadway Ballroom G-K
Coffee Break
10:05 a.m. - 10:30 a.m.
Location: Broadway Ballroom Foyer - E-poster Station 1
E-poster Session 4 - BPH / Incontinence
Moderator: Billy Cordon, MD
10:05 a.m. - 10:08 a.m.
Does Preoperative Bladder Compliance Affect Long-term Functional Outcomes after Laser Prostatectomy? (#329)
Speaker: Hwancheol Son, MD, PhD
10:08 a.m. - 10:11 a.m.
Prostatic Urethral Lift Procedure in Patients with Inflatable Penile Prosthesis - A Case Series (#326)
Speaker: Joseph Sarcona
10:11 a.m. - 10:14 a.m.
Symptom Relief and Sexual Function Improvement for Patients with All Types of Prostate Enlargement after Prostatic Urethral Lift (PUL) (#327)
Speaker: Robert Valenzuela, MD
10:14 a.m. - 10:17 a.m.
Improvement of Minimal Stress Urinary Incontinence after Mini-Jupette Sling Placement, During Penile Prosthesis Surgery, for Management of Post-Prostatectomy Climacturia (#328)
Speaker: Christopher Kannady
10:17 a.m. - 10:20 a.m.
Does Urethral Repair Prevent Complications from AUS Cuff Erosions? A Decade of Experience (#325)
Speaker: Kelly Caldwell
10:20 a.m. - 10:23 a.m.
Same-day Artificial Urinary Sphincter and Inflatable Penile Prosthesis Placement: Comparable Perioperative Outcomes (#330)
Speaker: Alexandra Carolan
10:23 a.m. - 10:26 a.m.
Clinical Outcomes of Prostatic Urethral Lift in Men With Enlarged Median Lobes Compared With Results From The L.I.F.T. Study (#331)
Speaker: Kelly Harris
10:05 a.m. - 10:30 a.m.
Location: Broadway Ballroom Foyer - E-poster Station 2
E-poster Session 5 - Erectile Dysfunction Surgical 2
Moderator: Seth Cohen, MD, MPH
10:05 a.m. - 10:08 a.m.
Challenging Ethical Scenarios in Penile Implant Surgery: A Survey of High-Volume Implanters (#332)
Speaker: Mark Ehlers
10:08 a.m. - 10:11 a.m.
Extended Experience with High Submuscular Placement of Inflatable Penile Prosthesis Reservoirs (#333)
Speaker: Mehraban Kavoussi
10:11 a.m. - 10:14 a.m.
Oxidized Regenerated Cellulose (FibrillarTM) Reduces Postoperative Corporal Bleeding and Patient-Initiated Phone Calls Following Inflatable Penile Prosthesis Surgery (#334)
Speaker: Avery Wolfe
10:14 a.m. - 10:17 a.m.
Motivational Factors for Surgical Intervention of Erectile Dysfunction (#335)
Speaker: C. Scott Collins
10:17 a.m. - 10:20 a.m.
Reservoir Induced Bladder Rupture: A Rare Complication of Inflatable Penile Prosthesis Revision Surgery (#336)
Speaker: Jessica Phelps
10:20 a.m. - 10:23 a.m.
Intraoperative Use of Vancomycin Paste During Penile Prosthesis Placement: Initial Outcomes (#337)
Speaker: Priyanka Bearelly
10:23 a.m. - 10:26 a.m.
Home Removal of Jackson-Pratt Drain Following Outpatient Penile Prosthesis Implantation (#338)
Speaker: Andrew Campbell
10:26 a.m. - 10:29 a.m.
Corporal Measurements of Korean Men Undergoing Inflatable Penile Prosthesis Implantation. Disagree with Myth of Smaller Asian Penis (#339)
Speaker: Kookbin Lee
10:29 a.m. - 10:32 a.m.
Current Practice in the Treatment of Infected Penile Prostheses: An Anonymous Survey of ISSM and GURS members (#364)
Speaker: Priyanka Bearelly
10:05 a.m. - 10:30 a.m.
Location: Broadway Ballroom Foyer - E-poster Station 3
E-poster Session 6 - Miscellaneous 1
Moderator: Nannan Thirumavalavan, MD
10:05 a.m. - 10:08 a.m.
Telesurgery: A Modern Take on Historical Surgical Education (#340)
Speaker: Brian Christine, MD
10:08 a.m. - 10:11 a.m.
"Doc, if it were you, what would you do?": A Survey of Men's Health Specialists' Personal Preferences Regarding Treatment Modalities (#341)
Speaker: Maxwell Towe
10:11 a.m. - 10:14 a.m.
Self-Reported Sexual Problems Predicts Higher Levels of Distress, Fatigue and Insomnia in Patients with Cancer (#342)
Speaker: Mary Hughes
10:14 a.m. - 10:17 a.m.
Sexual Outcomes After Empiric Medical Therapy for Male Infertility (#343)
Speaker: Nassim Lashkari
10:17 a.m. - 10:20 a.m.
Cost Analysis Comparing OR to Office-based Hydrocele and Spermatocele Excision (#344)
Speaker: Kevin Wymer
10:20 a.m. - 10:23 a.m.
Penile Plication is an Effective Treatment Option for Congenital Penile Curvature (#345)
Speaker: Peter Dietrich
10:23 a.m. - 10:26 a.m.
The Association Between Toxic Life Stress and Semen Quality (#346)
Speaker: Kajal Khodamoradi
10:26 a.m. - 10:29 a.m.
Association between Sexual Orientation and Prostate Cancer Screening (#347)
Speaker: Vivian Wong
10:30 a.m. - 12:00 p.m.
Location: Broadway Ballroom A-B
Translational Research in Sexual Medicine
Moderators: Trinity Bivalacqua, MD, PhD & Kelvin Davies, BSc, MSc, PhD
10:30 a.m. - 10:42 a.m.
The Gut Microbiome and Men's Health or Sexual Medicine or ED
Speaker: Faysal Yafi, MD, FRCSC
10:42 a.m. - 10:54 a.m.
Testosterone and Female Sexual Dysfunction
Speaker: Linda Vignozzi, MD
10:54 a.m. - 11:04 a.m.
Effect of Transendocardial Stem Cell Injection on Erectile Function in Men with Cardiomyopathy: Results from the TRIDENT and TAC-HFT Trials. (#009)
Speaker: Ranjith Ramasamy
11:04 a.m. - 11:14 a.m.
Research and Design of Novel Topically Applied Nanoparticle Systems to Deliver Erectogenic Agents (#010)
Speaker: Andrew Draganski
11:14 a.m. - 11:24 a.m.
Towards MRI-based Mapping and 3D Visualization of Erectile Nerves (#011)
Speaker: Vadim Mitrokhin
11:24 a.m. - 11:36 a.m.
Chemsex - The Sexual Response to Drugs in Animals and Humans
Speaker: James Pfaus, PhD
11:36 a.m. - 12:00 p.m.
Panel Discussion - Optimizing Research and Development Infrastructure at Institutions and in Private Practices - What are the Critical Pieces?
Speakers: Irwin Goldstein, MD; John Mulhall, MD & Chris Tihansky
10:30 a.m. - 12:00 p.m.
Location: Broadway Ballroom F
Peyronie's Disease
Moderators: Brian Christine, MD & Yutian Dai, MD, PhD
10:30 a.m. - 10:43 a.m.
Management of Acute Phase Peyronie's Disease
Speaker: Kenneth Delay, MD
10:43 a.m. - 10:56 a.m.
Tips for Management of Complications from CCH and PD Surgery
Speaker: Jonathan Clavell, MD
10:56 a.m. - 11:06 a.m.
Peyronie’s Disease and the Female Sexual Partner: A Comparison of the Male and Female Experience (#012)
Speaker: M. Ryan Farrell
11:06 a.m. - 11:16 a.m.
Should Men with Poor Results After Two Series of Collagenase Injections for Peyronie’s Disease Continue Therapy? (#013)
Speaker: Manaf Alom
11:16 a.m. - 11:26 a.m.
Significant Familial Clustering of Peyronie’s Disease in Close and Distant Relatives (#014)
Speaker: Alexander Pastuszak, MD, PhD
11:26 a.m. - 11:39 a.m.
PD Surgery: Graft Options in the Modern Day and Their Utility
Speaker: Laurence Levine, MD
11:39 a.m. - 12:00 p.m.
Debate - Is Mondor's Disease the Underlying Cause of Peyronies Disease?
Speakers: Andrew McCullough, MD & Landon Trost, MD
10:30 a.m. - 12:00 p.m.
Location: Broadway Ballroom C-D
BPH / Ejaculation - Moderated Posters
Moderators: Nikolai Sopko, MD, PhD & Peter Stahl, MD
10:45 a.m. - 10:50 a.m.
Evaluation of Bothersome/Distressing Penile Numbness with Orgasmic Dysfunction: Role of Neuro-Genital Testing to Localize the Site of Neurologic Pathology (#130)
Speaker: Irwin Goldstein, MD
10:50 a.m. - 10:55 a.m.
5 Years of Food and Drug Administration (FDA) Alternative Summary Reporting (ASR) of Adverse Events Associated with the Artificial Urinary Sphincter (#131)
Speaker: Rafael Schulman
10:55 a.m. - 11:00 a.m.
Evolution of BPH Healthcare Costs: 2004-2013 (#132)
Speaker: Petar Bajic, MD
11:00 a.m. - 11:05 a.m.
Comparison of BPH Medication Prescribing Among Sexagenarians with Medicare and Private Insurance (#133)
Speaker: Petar Bajic, MD
11:05 a.m. - 11:10 a.m.
Prevalence of Climacturia in Patients with History of Definitive Therapy for Prostate Cancer (#134)
Speaker: Masaya Jimbo
11:10 a.m. - 11:15 a.m.
Early Experience With Low-dose Adderall For Treatment Refractory Delayed Orgasm and Anorgasmia in Men (#135)
Speaker: Matthew Ziegelmann, MD
11:15 a.m. - 11:20 a.m.
Male Pre-surgical Incontinence Assessment: What Methods are Actually Being Used? (#136)
Speaker: Gerard Henry
11:20 a.m. - 11:25 a.m.
What Methods are Actually Being Used to Evaluate Male Incontinence Surgery Outcomes? (#137)
Speaker: Gerard Henry
11:25 a.m. - 11:30 a.m.
Androgen Deprivation Therapy is Associated With Urethral Atrophy and Artificial Urinary Sphincter Cuff Erosion (#138)
Speaker: Nicolas Ortiz
11:30 a.m. - 11:35 a.m.
Characterizing the Epidemiological Landscape of Post-Orgasmic Illness Syndrome (#139)
Speaker: Caleb Natale
11:35 a.m. - 11:40 a.m.
Continuation of Antiplatelet and/or Anticoagulation in Patients Undergoing Rezūm Prostate Ablation (#141)
Speaker: Ajay Gopalakrishna
11:40 a.m. - 11:45 a.m.
Predictors of Intravaginal Ejaculatory Latency Time Among a Cohort of Men Presenting to a Sexual Medicine Clinic (#142)
Speaker: Ajay Gopalakrishna
11:45 a.m. - 11:50 a.m.
Successful Treatment of Recurrent Bilateral Corpora Cavernosal Abscesses using the Carrion Cast: A Novel Case Study (#143)
Speaker: Lael Reinstatler
11:50 a.m. - 11:55 a.m.
Post-Orgasmic Illness Syndrome: A Case Report and Literature Review with Contemporary Treatment Considerations (#144)
Speaker: Hudson Pierce
Afternoon
12:00 p.m. - 01:30 p.m.
Location: Broadway Ballroom E
Industry Sponsored Lunch Symposium
01:30 p.m. - 01:45 p.m.
Location: Broadway Ballroom F
AUA Update
Moderator: Hossein Sadeghi-Nejad, MD, FACS
Speaker: John Denstedt, MD, FRCSC, FACS, FCAHS
01:30 p.m. - 03:30 p.m.
Location: Broadway Ballroom A-B
Female Sexual Dysfunction - Medical & Surgical Session 2
Moderators: Sue Goldstein, BA, CCRC, AASECT-CSE & Sherita King, MD
01:30 p.m. - 01:48 p.m.
Testosterone Treatment in HSDD
Speaker: Noel Kim, PhD
01:48 p.m. - 02:06 p.m.
Sexual Pain Management - Medical and Surgical
Speaker: Irwin Goldstein, MD
02:06 p.m. - 02:24 p.m.
How to Deal With the Partner of a Man Getting Treated for ED
Speaker: Rachel Rubin, MD
02:24 p.m. - 02:34 p.m.
Open-Label Pilot, Prospective Vulvoscopic Study During Four Months of Administration of Daily Prasterone (6.5 mg DHEA) Vaginal Inserts in Women with Moderate to Severe Dyspareunia from Vulvar Vaginal Atrophy (VVA) Due to Menopause: An Interim Analysis (#018)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE
02:34 p.m. - 02:44 p.m.
Safety and Efficacy of CO2 Fractional Laser Therapy in Women with Vestibulodynia (#019)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE
02:44 p.m. - 02:54 p.m.
Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With Hypoactive Sexual Desire Disorder (#020)
Speaker: Anita Clayton
02:54 p.m. - 03:19 p.m.
Panel Discussion - The Changing Landscape of FSD - What the Future Holds
Speakers: Irwin Goldstein, MD; James Pfaus, PhD & Tami Rowen, MD, MS, FACOG
03:19 p.m. - 03:30 p.m.
Q&A
01:30 p.m. - 03:30 p.m.
Location: Broadway Ballroom C-D
Succeeding as a Researcher: Grants, Manuscripts, Labs, etc.
Moderators: Kelvin Davies, BSc, MSc, PhD & Johanna Hannan, PhD
01:30 p.m. - 01:48 p.m.
Manuscript Writing: Practices and Pitfalls
Speaker: Trinity Bivalacqua, MD, PhD
01:48 p.m. - 02:06 p.m.
Grant Writing: A Template for Success
Speaker: Johanna Hannan, PhD
02:06 p.m. - 02:24 p.m.
Funding Opportunities (in Sexual Medicine) for Urologists
Speaker: Carolyn Best, PhD
02:24 p.m. - 02:42 p.m.
Manuscript Review - How Can I Be a Great Reviewer?
Speaker: John Mulhall, MD
02:42 p.m. - 03:00 p.m.
Starting a Successful Lab (in Sexual Medicine)
Speaker: Alexander Pastuszak, MD, PhD
03:00 p.m. - 03:20 p.m.
Panel Discussion - What I Need to Know to Write a Successful Grant and Paper
Speakers: Carolyn Best, PhD; Trinity Bivalacqua, MD, PhD; Johanna Hannan, PhD & Alexander Pastuszak, MD, PhD
03:20 p.m. - 03:30 p.m.
Q&A
01:45 p.m. - 03:30 p.m.
Location: Broadway Ballroom F
Sexual Dysfunction in Transgender / Gender Affirmed Populations
Moderators: Maurice Garcia, MD, MAS; Lawrence Hakim, MD, FACS & Stanton Honig, MD
01:45 p.m. - 02:00 p.m.
Hormone Management in the Transgender Population
Speaker: Lawrence Hakim, MD, FACS
02:00 p.m. - 02:08 p.m.
Sexual Dysfunction in Transgender Men and Women Following Gender Affirming Surgery - Female to Male
Speaker: Ethan Grober, MD, MEd, FRCSC
02:08 p.m. - 02:15 p.m.
Sexual Dysfunction in Transgender Men and Women Following Gender Affirming Surgery - Male to Female
Speaker: Yonah Krakowsky, MD
02:15 p.m. - 02:25 p.m.
Patient Reported Outcomes of a Robotic-Assisted Double-Skin Flap Vaginoplasty Technique for Gender Affirmation (#015)
Speaker: Jessica Phelps
02:25 p.m. - 02:35 p.m.
Establishing a Multidisciplinary, Academic Program in Penile Inversion Vaginoplasty (#016)
Speaker: Yonah Krakowsky, MD
02:35 p.m. - 02:45 p.m.
Novel Technique for Extra-Corporal Placement of Penile Prosthesis in Cis and Transgender Male: The Modified Use of Advance Male sling for Proximal Anchoring (#017)
Speaker: Laith Alzweri
02:45 p.m. - 03:00 p.m.
Sexual Dysfunction Following Gender Affirming Medical Therapy
Speaker: Maurice Garcia, MD, MAS
03:00 p.m. - 03:20 p.m.
Debate - Gender Affirming Surgery Should / Should Not Be Offered Before Age 18
Speakers: Maurice Garcia, MD, MAS & Stanton Honig, MD
03:20 p.m. - 03:30 p.m.
Q&A
03:30 p.m. - 04:00 p.m.
Location: Broadway Ballroom G-K
Coffee Break
03:35 p.m. - 04:00 p.m.
Location: Broadway Ballroom Foyer - E-poster Station 1
E-poster Session 7 - Peyronie's Disease 1
Moderator: Jason Jameson, MD
03:35 p.m. - 03:38 p.m.
Retrospective Claims Analysis of Patients' Characteristics Affecting the Choice of Treatment Among Patients with Peyronie's Disease (#348)
Speaker: Vladimir Zah
03:38 p.m. - 03:41 p.m.
Penile Duplex Ultrasonography Supplements Goniometry in Formal Assessment of Efficacy of Intralesional Collagenase Clostridium Histolyticum for Peyronie's Disease (#349)
Speaker: Arash Amighi
03:41 p.m. - 03:44 p.m.
Long-term Curvature Deformity Characterization in Patients Previously Treated With Collagenase Clostridium Histolyticum for Peyronie’s Disease by Plaque Calcification (#350)
Speaker: Irwin Goldstein, MD
03:44 p.m. - 03:47 p.m.
Modified Grid Plaque Incision and Sealing with Collagen Fleece for Treatment of Peyronie’s Disease: Its feasibility and safety (#351)
Speaker: Du Geon Moon
03:47 p.m. - 03:50 p.m.
Therapeutic Trends in the Management of Patients with Peyronie's Disease (#352)
Speaker: Landon Trost, MD
03:50 p.m. - 03:53 p.m.
Treatment Related Outcomes for Patients with Atypical Peyronie's Disease using Xiaflex Injections (#353)
Speaker: Farouk M. El-Khatib
03:53 p.m. - 03:56 p.m.
Peyronie's Disease: What Role Does Prostate Radiation Play? (#354)
Speaker: Valary Raup
03:56 p.m. - 03:59 p.m.
Safety and Efficacy of Intralesional Collagenase Clostridium Histolyticum Injection Therapy in the Acute Phase of Peyronie's Disease: A Single-center, Retrospective Cohort Study (#355)
Speaker: Dyvon Walker
03:35 p.m. - 04:00 p.m.
Location: Broadway Ballroom Foyer - E-poster Station 2
E-poster Session 8 - Priapism / Trauma / Reconstruction
Moderator: Lawrence Jenkins, MD, MBA
03:35 p.m. - 03:38 p.m.
Age Greater Than 60 Is Associated with Decreased Success in Bulbar Stricture Repair (#356)
Speaker: Jeffrey Wooliscroft
03:38 p.m. - 03:41 p.m.
Penoscrotal Decompression as a Glans Sparing Alternative to Shunt Procedures for Surgical Relief of Refractory Ischemic Priapism (#357)
Speaker: Adam Baumgarten
03:41 p.m. - 03:44 p.m.
The Pelvic Pop: A Case of Internal Penile Fracture Presenting with Scrotal Hematoma (#363)
Speaker: Michael Rezaee
03:44 p.m. - 03:47 p.m.
Surgical Management of Massive Localized Lymphedema of the Scrotum: A Single Institution Experience (#359)
Speaker: Raymond Costabile
03:47 p.m. - 03:50 p.m.
Contemporary Diagnostic Evaluation of Traumatic Penile Injuries (#360)
Speaker: Matthew Houlihan
03:50 p.m. - 03:53 p.m.
Evolution of Radial Forearm Free Flap Neophallus Construction for Future Prosthetic Intervention and Decreased Urinary Complications in Cis-Male Patients (#361)
Speaker: Christopher Koller
03:53 p.m. - 03:56 p.m.
Walt Whitman, John Mahay, and Urotrauma in the American Civil War (#362)
Speaker: Eric Mathews
03:56 p.m. - 03:59 p.m.
Which U.S. States' Medicaid Programs Provide Coverage for Genital Gender Affirming Surgery for Transgender Patients? A State-by-state Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services (#410)
Speaker: Maurice Garcia, MD, MAS
03:59 p.m. - 04:02 p.m.
How Early in Life do Transgender Patients Begin to Experience Gender Dysphoria? Why This Matters for Providers and Our Healthcare System (#411)
Speaker: Maurice Garcia, MD, MAS
03:35 p.m. - 04:00 p.m.
Location: Broadway Ballroom Foyer - E-poster Station 3
E-poster Session 9 - Erectile Dysfunction Medical / Surgical
Moderator: Amin Herati, MD
03:38 p.m. - 03:41 p.m.
Penile Length As A Measure Of Patient Satisfaction After Penile Prosthesis Surgery (#365)
Speaker: Christopher Kannady
03:41 p.m. - 03:44 p.m.
Factors Impacting Post-operative Opioid Use among Patients Undergoing Implantation of Inflatable Penile Prosthesis (#366)
Speaker: Jason Akerman, MD
03:44 p.m. - 03:47 p.m.
Intracavernous Injection of PGE1 and Couple Collaborative Treatment for PDE5i-resistant Psychogenic ED (#367)
Speaker: Wei Liu
03:47 p.m. - 03:50 p.m.
Beyond the Pill: Preliminary Data Looking at a Combination of Phosphodiesterase Inhibitors With Low Dose Bimix Intra-urethral Gel for the Management of Erectile Dysfunction (#368)
Speaker: Daniel Martinez
03:50 p.m. - 03:53 p.m.
Pressure Necrosis of Proximal Corpora in Elite Ironman Resulting in Massive Venous Leak (#369)
Speaker: James Trussler
03:53 p.m. - 03:56 p.m.
Increasing the Dose of Vardenafil on a Daily Base Doesn't Improve Erectile Function in the Longer Follow-up of 2 Years After Nerve-sparing Radical Prostatectomy (#370)
Speaker: Andreas Bannowsky
03:56 p.m. - 03:59 p.m.
Erectile Dysfunction Management Preferences in Hispanic Males (#371)
Speaker: Christopher Kannady
04:00 p.m. - 05:30 p.m.
Location: Broadway Ballroom C-D
Peyronie's Disease / Reconstruction - Moderated Posters
Moderators: Paul Gittens, MD & Amin Herati, MD
04:15 p.m. - 04:20 p.m.
Addressing Sexual Health in Women After Pelvic Fracture: A Cross-Sectional Survey (#145)
Speaker: Niels Johnsen
04:20 p.m. - 04:25 p.m.
Opioid and Non-Opioid Pain Management Pathways for Male Anterior Urethroplasty: Evidence-Based Approach for Opioid Stewardship (#146)
Speaker: Jason Joseph
04:25 p.m. - 04:30 p.m.
A Prospective Phase II, Open-Label, Single-arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients With Priapism (SPARTAN) (#147)
Speaker: Arthur Burnett, MD
04:30 p.m. - 04:35 p.m.
Imbalance in Presentation of Risks and Benefits of Penile Enhancement Procedures in Direct-to-Patient Online Marketing (#159)
Speaker: Daniel Tennenbaum
04:35 p.m. - 04:40 p.m.
6-Month Outcomes of RestoreX Penile Traction Therapy in Men with Peyronie's Disease: A Randomized, Controlled Trial (#149)
Speaker: Matthew Ziegelmann, MD
04:40 p.m. - 04:45 p.m.
The Impact Of Surgical Treatment Of Penile Fracture On Long-term Erectile and Urinary Functions (#150)
Speaker: Caleb Natale
04:45 p.m. - 04:50 p.m.
A Novel Hematoma Classification System Standardizes the Reporting of Adverse Events after Intralesional Collagenase Injection: Application to a Modified Injection Technique (#151)
Speaker: Justin Houman
04:50 p.m. - 04:55 p.m.
Multi-Center Experience Utilizing Collagen Fleece for Plaque Incision with Grafting to Correct Residual Curvature at Time of Inflatable Penile Prosthesis Placement in Peyronie's Disease Patients (#152)
Speaker: David Yang
04:55 p.m. - 05:00 p.m.
The Use of Penile Computed Tomography Cavernosogram (CTC) in the Evaluation of Peyronie's Disease (#153)
Speaker: James Trussler
05:00 p.m. - 05:05 p.m.
Continued Improvement After More than Eight Injections of Collagenase Clostridium Histolyticum for Peyronie's Disease (#154)
Speaker: Andrew Sun
05:05 p.m. - 05:10 p.m.
Intensity of Preoperative testing for Urethroplasty and its association with outcomes- A Propensity Score-Matched Analysis (#155)
Speaker: Wade Muncey
05:10 p.m. - 05:15 p.m.
Intralesional Collagenase Clostridium Histolyticum Therapy for Peyronie's Disease is Safe in Patients Continuing Antiplatelet and Anticoagulant Therapy: A Single Center Experience (#156)
Speaker: Arash Amighi
05:15 p.m. - 05:20 p.m.
Defining the Impact of Peyronie's Disease on Psychosocial Status in Gay versus Heterosexual Men (#157)
Speaker: Carolyn Salter
05:20 p.m. - 05:25 p.m.
Penile Surgery is Associated with a Higher Rate of Penile Complications and Pain Medication Use Compared to Collagenase Clostridium Histolyticum in Patients with Peyronie's Disease (#158)
Speaker: Landon Trost, MD
05:25 p.m. - 05:30 p.m.
Trazodone Pre-treatment Screening and Side Effects Counseling at a Single Veterans Affairs Hospital (#148)
Speaker: Tejash Shah
04:00 p.m. - 05:30 p.m.
Location: Broadway Ballroom F
BPH / Incontinence
Moderators: Gregory Broderick, MD & Omer Raheem, MD
04:00 p.m. - 04:15 p.m.
Updates in BPH and Incontinence - Most Important Literature of 2018-2019
Speaker: Helen Bernie, DO, MPH
04:15 p.m. - 04:30 p.m.
Minimally Invasive Sex Preserving Treatment Options for LUTS/BPH
Speaker: Amy Pearlman, MD
04:30 p.m. - 04:45 p.m.
How do Prostatic Lift, Water Vapor Therapy, and Laser Enucleation Compare to TURP?
Speaker: Nikhil Gupta, MD
04:45 p.m. - 04:55 p.m.
Do Prior Anti-incontinence Procedures Influence the Success of Artificial Urinary Sphincter Placement? (#021)
Speaker: Emily Yura
04:55 p.m. - 05:05 p.m.
The Impact Of Obesity On Perioperative Outcomes Following Placement Of Artificial Urinary Sphincter: National Multi-institutional Analysis of the National Surgical Quality Improvement Program (NSQIP) Database (#023)
Speaker: Omer Raheem, MD
05:05 p.m. - 05:30 p.m.
Panel Discussion - How I Choose the Right BPH / Incontinence Treatment for My Patients
Speakers: Amy Guise, MD; Nikhil Gupta, MD & Jed Kaminetsky, MD
04:00 p.m. - 05:30 p.m.
Location: Broadway Ballroom A-B
Sexual Medicine from European Perspectives (ESSM Session)
Moderator: Yacov Reisman, MD
04:00 p.m. - 04:20 p.m.
ESSMs Recent Developments in Sexual Medicine
Speaker: Yacov Reisman, MD
04:20 p.m. - 04:40 p.m.
Peyronies Surgery: Petch Dilemma
Speaker: Carlo Bettocchi, MD
04:40 p.m. - 05:00 p.m.
Recent Technological Advances in Male Sexual Dysfunction
Speaker: Arik Shechter, MD
05:00 p.m. - 05:20 p.m.
Lifestyle Intervention and Mens Health
Speaker: Yacov Reisman, MD
05:20 p.m. - 05:30 p.m.
Q&A
05:30 p.m. - 06:00 p.m.
Location: Broadway Ballroom F
SMSNA Business Meeting (members only)
Evening
06:00 p.m. - 07:00 p.m.
Location: Legends F-G
Young Clinicians Mixer
07:00 p.m. - 10:30 p.m.
Location: Country Music Hall of Fame
SMSNA Foundation Night and Gala Dinner
Saturday, October 26, 2019
Morning
07:00 a.m. - 08:00 a.m.
Location: Broadway Ballroom E
Industry Sponsored Breakfast Symposium
08:00 a.m. - 10:00 a.m.
Location: Broadway Ballroom F
Erectile Dysfunction - Medical
Moderators: Helen Bernie, DO, MPH & John Mulhall, MD
08:00 a.m. - 08:15 a.m.
Sexuality Following Radical Prostatectomy: Is Restoration of Erectile Function Enough?
Speaker: Omer Raheem, MD
08:15 a.m. - 08:30 a.m.
Utility of Penile Doppler for the Diagnosis of ED
Speaker: Alan Shindel, MD
08:30 a.m. - 08:45 a.m.
Genetics of Erectile Dysfunction
Speaker: James Hotaling, MD
08:45 a.m. - 08:55 a.m.
Advanced Glycation End-products Measuring with Skin Auto Fluorescence: Correlation with Diabetic Erectile Dysfunction and Non-diabetic Erectile Dysfunction (#024)
Speaker: Heung Jae Park
08:55 a.m. - 09:05 a.m.
Efficacy of RestoreX Penile Traction Therapy in Improving Penile Length and Erectile Function Post Prostatectomy (#025)
Speaker: Landon Trost, MD
09:05 a.m. - 09:15 a.m.
Erectile Dysfunction in Telemedicine: The Standardized Patient Experience (#026)
Speaker: Shervin Badkhshan
09:15 a.m. - 09:30 a.m.
ED and CV risk - Updates on the Evidence Base
Speaker: Martin Miner, MD
09:30 a.m. - 09:50 a.m.
Panel Discussion - When Should ED Trigger a Cardiology Referral / Workup?
Speakers: Stephen Kopecky, MD; Martin Miner, MD & Landon Trost, MD
09:50 a.m. - 10:00 a.m.
Q&A
10:00 a.m. - 10:30 a.m.
Location: Broadway Ballroom G-K
Coffee Break
10:05 a.m. - 10:30 a.m.
Location: Broadway Ballroom Foyer - E-poster Station 1
E-poster Session 10 - Androgens
Moderator: Ashley Tapscott, DO
10:05 a.m. - 10:08 a.m.
Baseline Gonadotropin Levels do not Predict Testosterone Response in Hypogonadal Men Treated with Clomiphene Citrate (#372)
Speaker: Lindsey Wright
10:08 a.m. - 10:11 a.m.
Testosterone therapy in Men on Active Surveillance for Prostate Cancer (#373)
Speaker: Helen Bernie, DO, MPH
10:11 a.m. - 10:14 a.m.
Testosterone Patient Journey Analysis (#374)
Speaker: Irwin Goldstein, MD
10:14 a.m. - 10:17 a.m.
Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-term Testosterone Therapy for up to 12 Years in a Real-life Registry Study (#375)
Speaker: Karim Sultan Haider
10:17 a.m. - 10:20 a.m.
Prostate Cancer (PCa) Incidence and Severity in 823 Hypogonadal Men With and Without Testosterone Therapy (TTh) in a Controlled, Observational Registry Implying 7,116 Patient-years (#376)
Speaker: Ahmad Haider
10:20 a.m. - 10:23 a.m.
Pretreatment Estradiol Does Not Predict Improvement in Serum Testosterone in Men Receiving Clomiphene Citrate (#377)
Speaker: Thomas Masterson, MD
10:23 a.m. - 10:26 a.m.
Improvement of Erectile Function in Hypogonadal Men Receiving Long-term Treatment with Testosterone Compared to a Hypogonadal Control Group: 7116 Patient-years of Clinical Experience (#378)
Speaker: Karim Sultan Haider
10:26 a.m. - 10:29 a.m.
Symptomatic Response to TLANDO in Patients that do not Achieve T Cavg > 300 ng/dL (#379)
Speaker: Nachiappan Cidambaram
10:05 a.m. - 10:30 a.m.
Location: Broadway Ballroom Foyer - E-poster Station 2
E-poster Session 11 - Peyronie's Disease 2
Moderator: Faysal Yafi, MD, FRCSC
10:05 a.m. - 10:08 a.m.
Intralesional Collagenase Clostridium Histolyticum Achieves Greater Curvature Improvements Compared to Interferon for Peyronie's Disease (#380)
Speaker: Manaf Alom
10:08 a.m. - 10:11 a.m.
Conservative Management of Suspected Fractures in Men Undergoing Collagenase Clostridium Histolyticum for Peyronie's Disease Is not Associated with Worsening of Erectile Function (#381)
Speaker: Kiran Sharma
10:11 a.m. - 10:14 a.m.
Factors Associated with Consideration of Surgical Straightening in Men with Peyronie's Disease (#382)
Speaker: Raevti Bole
10:14 a.m. - 10:17 a.m.
An Updated Evaluation of Provider Utilization and Medicare Reimbursement for Commonly Treated Sexual Medicine Conditions (#383)
Speaker: Lael Reinstatler
10:17 a.m. - 10:20 a.m.
Likelihood of Subsequent Penile Surgery for Patients with Peyronie's Disease Previously Treated with Collagenase Clostridium Histolyticum or Penile Surgery (#384)
Speaker: Landon Trost, MD
10:20 a.m. - 10:23 a.m.
Occurrence of Adverse Events Does Not Impact Efficacy of Collagenase Clostridium Histolyticum Therapy for Peyronie's Disease (#385)
Speaker: Dyvon Walker
10:23 a.m. - 10:26 a.m.
Erectile Dysfunction in Peyronie's Disease is Independent of Cavernosal Inflammation and Fibrosis (#386)
Speaker: Jeffrey Campbell
10:26 a.m. - 10:29 a.m.
Peyronie's Disease and Its Comorbidities: A Multi-Year, Single Institution Analysis (#387)
Speaker: Govind Shantharam
10:05 a.m. - 10:30 a.m.
Location: Broadway Ballroom Foyer - E-poster Station 3
E-poster Session 12 - Erectile Dysfunction Surgical 3
Moderator: Amy Pearlman, MD
10:05 a.m. - 10:08 a.m.
Decreased Skin Contact via “No-Touch” Surgical Technique Shifts Causative Microorganisms in Inflatable Penile Prosthesis (#388)
Speaker: Daniel E. Nassau
10:08 a.m. - 10:11 a.m.
Penile Prosthesis Glans Hypermobility Scale (GHS): Incidence, Severity, and Predictors in a Multi-Institutional Series (#389)
Speaker: Alfredo Suarez-Sarmiento, Jr.
10:11 a.m. - 10:14 a.m.
A Thematic Analysis of the Online Discussion Board, FrankTalk, Regarding Penile Implant (#390)
Speaker: Jennifer Lu
10:14 a.m. - 10:17 a.m.
Revision Inflatable Penile Prosthesis (IPP) Failure Rates and Risk Factors for Failure (#391)
Speaker: Steven Lomax
10:17 a.m. - 10:20 a.m.
Do We Really Need a Catheter Post IPP? Urinary Retention Prevalence and Considerations (#392)
Speaker: Lexiaochuan Wen
10:20 a.m. - 10:23 a.m.
Low-Intensity Shockwave Therapy for the Treatment of Erectile Dysfunction (#393)
Speaker: Jason Levy
10:23 a.m. - 10:26 a.m.
Out-patient Penile Prosthesis Surgery: an institutional Study (#394)
Speaker: Alfredo Suarez-Sarmiento, Jr.
10:26 a.m. - 10:29 a.m.
A Prospective Evaluation of Diabetic Patients Receiving Inflatable Penile Prosthesis (#395)
Speaker: Alfredo Suarez-Sarmiento, Jr.
10:30 a.m. - 12:00 p.m.
Location: Broadway Ballroom F
International Perspectives on Sexual Health
Moderators: Lawrence Jenkins, MD, MBA & Run Wang, MD, FACS
10:30 a.m. - 10:45 a.m.
Sexual Health Needs After Cancer: A Kenyan Perspective
Speaker: Phillip Odiyo
10:45 a.m. - 11:00 a.m.
Sexual Medicine: Chinese Perspective
Speaker: Yutian Dai, MD, PhD
11:00 a.m. - 11:15 a.m.
Sexual Health Strategies After Cancer Therapy: A Global Perspective
Speaker: Luca Incrocci, MD, PhD
11:15 a.m. - 11:30 a.m.
Sexual Health and Dysfunction Across South America
Speaker: Luiz Otavio Torres, MD
11:30 a.m. - 11:50 a.m.
Panel Discussion - Delivery of Sexual Medicine in Different Regions of the World
Speakers: Kathryn Hall, PhD; Luca Incrocci, MD, PhD; Phillip Odiyo & Luiz Otavio Torres, MD
11:50 a.m. - 12:00 p.m.
Q&A
10:30 a.m. - 12:00 p.m.
Location: Broadway Ballroom C-D
Cancer Survivorship / Basic Science - Moderated Posters
Moderators: Kelli Gross, MD & Pedro Maria, DO
10:45 a.m. - 10:50 a.m.
Canadian TrueNTH Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients: Results of a Feasibility Study (#160)
Speaker: Andrew Matthew, PhD
10:50 a.m. - 10:55 a.m.
Head and Neck Cancer Survivors' Perceptions of Self-report Measures Used to Assess Sexuality (#161)
Speaker: Bethany Rhoten
10:55 a.m. - 11:00 a.m.
Coping with the Sexual Side-effects of Prostate Cancer Treatment: it's a Couple Affair (#162)
Speaker: Daniela Wittmann, PhD, LMSW
11:00 a.m. - 11:05 a.m.
Sexual Concerns of Female Partners of Prostate Cancer Patients: Novel Data from an Online Health Community (#163)
Speaker: Stacy Loeb
11:05 a.m. - 11:10 a.m.
Sexual and Voiding Outcomes in Post-penectomy Penile Cancer Patients; A 5-year Follow-up (#164)
Speaker: Florian Stroie
11:10 a.m. - 11:15 a.m.
Results of the Critical Appraisal of the Sexual Health Rehabilitation Action Plan (SHRAP) (#165)
Speaker: Christine Zarowski, BSN, RN
11:15 a.m. - 11:20 a.m.
Attitudes, Practices, and Barriers to Sexual Health Assessments of Patients Amongst Practicing Oncologists: Survey Data from a Group of Local Oncology Healthcare Providers (#166)
Speaker: Justin Dubin
11:20 a.m. - 11:25 a.m.
Barriers to Evaluate Sexual Health Among Adolescent Young Adult Males with Cancer (#167)
Speaker: Justin Dubin
11:25 a.m. - 11:30 a.m.
Targeted Depletion of the Enzyme Fidgetin-like 2 Promotes Axon Regeneration and Improves Erectile Function Outcomes in a Rodent Model of Radical Prostatectomy (#168)
Speaker: Lisa Baker
11:30 a.m. - 11:35 a.m.
COMP-4 Reduces Oxidative Stress Markers in the Rat Corpora Cavernosa and Media of the Penile Dorsal Artery (#169)
Speaker: Sabine Nguyen
11:35 a.m. - 11:40 a.m.
Evaluation of Paracrine Factors Critical for Human Leydig Stem Cell Function (#170)
Speaker: Ranjith Ramasamy
11:40 a.m. - 11:45 a.m.
Increased Level of Tumor Necrosis Factor-alpha (TNFA) Leads to Downregulation of Nitrergic Neurons Following Bilateral Cavernous Nerve Injury and TNFA Inhibition Can Enhance Penile Smooth Muscle Relaxation by Upregulating Expression of Nitrergic Neurons (#171)
Speaker: Hotaka Matsui
11:45 a.m. - 11:50 a.m.
Caspase Signalling in ED Patients and Animal Models (#172)
Speaker: Carol Podlasek, PhD
11:50 a.m. - 11:55 a.m.
Sonic Hedgehog Responsive Apoptotic Signaling in Control and CN Crushed Rat Penis (#173)
Speaker: Carol Podlasek, PhD
11:55 a.m. - 12:00 p.m.
Optimization of Sonic Hedgehog Delivery to the Penis from Self-assembling Nanofiber Hydrogels to Preserve Penile Morphology after Cavernous Nerve Injury (#174)
Speaker: Carol Podlasek, PhD
10:30 a.m. - 12:00 p.m.
Location: Broadway Ballroom A-B
Lifestyle Medicine
Moderators: Jason Kovac, MD, PhD, FRCSC & Larry Lipshultz, MD
10:30 a.m. - 10:45 a.m.
Growth Hormone: Its History and Uses Over Time
Speaker: Seth Cohen, MD, MPH
10:45 a.m. - 11:00 a.m.
Growth Hormone Secretagogues: Adjuncts to Testosterone Therapy?
Speaker: Jason Kovac, MD, PhD, FRCSC
11:00 a.m. - 11:15 a.m.
Lifestyle Management, Nutrition and Nutritional Supplements: Facts and Fiction
Speaker: David Shin, MD
11:15 a.m. - 11:25 a.m.
Nandrolone Decanoate Improves Joint Pain in Hypogonadal Men Within 8 Weeks: Updates to a Novel Prospective Pilot Study (#027)
Speaker: Alexander Tatem, MD
11:25 a.m. - 11:40 a.m.
Botox in Sexual Medicine and Urology - When and Where?
Speaker: Wayne Hellstrom, MD
11:40 a.m. - 12:00 p.m.
Debate - GH and GH Secretagogues are Just Part of the Steroid Problem
Speakers: Lawrence Jenkins, MD, MBA & Alexander Tatem, MD
Afternoon
12:00 p.m. - 01:30 p.m.
Location: Broadway Ballroom E
Industry Sponsored Lunch Symposium
01:30 p.m. - 03:00 p.m.
Location: Broadway Ballroom F
Erectile Dysfunction - Surgical
Moderators: Haocheng Lin, MD, PhD & Landon Trost, MD
01:30 p.m. - 01:43 p.m.
Use of Antiseptics and Antibiotics at Time of IPP Salvage - What is the Evidence and Best Practice?
Speaker: Tobias Kohler, MD, MPH
01:43 p.m. - 01:56 p.m.
Updates on Penile Length and Girth Enhancement Procedures
Speaker: Robert Valenzuela, MD
01:56 p.m. - 02:06 p.m.
Adherence to the AUA Penile Prosthesis Antibiotic Prophylaxis Guidelines in Diabetic Patients is Associated with Significantly Higher Risks of Device Infection (#028)
Speaker: Maxwell Towe
02:06 p.m. - 02:16 p.m.
Penile Prosthesis Insertion in the Era of Antibiotic Stewardship: Are Postoperative Antibiotics Necessary? (#029)
Speaker: Benjamin Dropkin
02:16 p.m. - 02:26 p.m.
Assessment of The Effect of Girth Restriction on Inflatable Penile Implant Length Expansion (#030)
Speaker: Marah C. Hehemann
02:26 p.m. - 02:39 p.m.
Dorsal Vein Sacrifice During Radical Prostatectomy, A Possible Contributing Cause of ED?
Speaker: Arthur Burnett, MD
02:39 p.m. - 03:00 p.m.
Panel Discussion - Should IPP Insurance Coverage Be Mandated?
Speakers: Samir Bhattacharyya, PhD; Mark Fligge & Larry Lipshultz, MD
01:30 p.m. - 03:00 p.m.
Location: Broadway Ballroom C-D
Androgens - Moderated Posters
Moderators: Billy Cordon, MD & Saneal Rajanahally, MD
01:45 p.m. - 01:50 p.m.
An Evidence-Based Analysis of Ingredients in Popular Supplements for Low Testosterone (#175)
Speaker: Manish Kuchakulla
01:50 p.m. - 01:55 p.m.
Comparison of Pharmacokinetic Profiles of Testosterone Therapy Products in Relation to Diurnal Variation of Serum Testosterone Levels (#176)
Speaker: Alexander Pastuszak, MD, PhD
01:55 p.m. - 02:00 p.m.
Low T on Social Media: Using a Big Data Approach to Understand Patients' Anxieties about Hypogonadism and Testosterone Replacement Therapy (#177)
Speaker: Vadim Osadchiy
02:00 p.m. - 02:05 p.m.
Effect of Natesto® on Health Related Quality of Life and Erectile Function: Analysis of Results from a Prospective Phase IV Clinical Trial (#178)
Speaker: Joshua Bitran
02:05 p.m. - 02:10 p.m.
Prolactin to Testosterone Ratio Predicts Pituitary Adenomas in Young Men with Mild Hyperprolactinemia (#179)
Speaker: Bryan Naelitz
02:10 p.m. - 02:15 p.m.
The Effect of Long Acting vs Short Acting Testosterone Therapy on Gonadotropins: A Systematic Review (#180)
Speaker: Thomas Masterson, MD
02:15 p.m. - 02:20 p.m.
Association between Polychlorinated Biphenyl (PCB) 153 Exposure and Serum Testosterone Levels: Analysis of the National Health and Nutrition Examination Survey (#181)
Speaker: Joon Yau Leong
02:20 p.m. - 02:25 p.m.
Improved Patient Reported Sexual and Mental Domain Outcomes with Oral Testosterone (TLANDO) Relative to Topical Testosterone in Treated Hypogonadal Men (#182)
Speaker: Anthony DelConte
02:25 p.m. - 02:30 p.m.
Obstructive Sleep Apnea Increases the Risk of Secondary Polycythemia in Hypogonadal Men Receiving Testosterone Replacement Therapy (#183)
Speaker: Scott Lundy
02:30 p.m. - 02:35 p.m.
Evaluation of YouTube Videos on Male Hypogonadism (#184)
Speaker: Christopher Warren
02:35 p.m. - 02:40 p.m.
Prevalence of Bone Density Loss in Men with Low and Equivocal Testosterone Levels (#185)
Speaker: Carolyn Salter
02:40 p.m. - 02:45 p.m.
Testosterone Therapy in Men with Gleason 6-7 Prostate Cancer (#186)
Speaker: Carolyn Salter
02:45 p.m. - 02:50 p.m.
Improvement of Metabolic Syndrome (MetS) Parameters in Men with Hypogonadism With and Without Testosterone Therapy (TTh): Real-Life Evidence from more than 7,000 Patient-Years (#187)
Speaker: Farid Saad, DVM, PhD
02:50 p.m. - 02:55 p.m.
Comparative Assessment of Outcomes Using Two Different Intramuscular Testosterone Replacement Therapy Regimens (#188)
Speaker: Farouk M. El-Khatib
02:55 p.m. - 03:00 p.m.
Biochemical Recurrence Rates In Men With High Grade Prostate Cancer on Testosterone Therapy (#189)
Speaker: Helen Bernie, DO, MPH
01:30 p.m. - 03:30 p.m.
Location: Broadway Ballroom A-B
The Business of Sexual Medicine
Moderators: Martin Miner, MD & Amy Pearlman, MD
01:30 p.m. - 01:50 p.m.
Considerations for a Successful Mens Health Clinic
Speaker: Jesse Mills, MD
01:50 p.m. - 02:10 p.m.
Billing and Coding in Mens Health: Optimizing your Revenue Stream
Speaker: Edward Karpman, MD
02:10 p.m. - 02:30 p.m.
Social Media in Mens Health
Speaker: Jonathan Beilan, MD
02:30 p.m. - 02:50 p.m.
Telemedicine in Sexual Health
Speaker: Neil Baum, MD
02:50 p.m. - 03:10 p.m.
Entrepreneurship in Sexual Medicine: How to Translate Your Ideas Into Companies
Speaker: James Hotaling, MD
03:10 p.m. - 03:30 p.m.
Panel discussion: Academic vs. Private Practice and Care Delivery in Sexual Medicine - Is There a Best Model?
Speakers: James Hotaling, MD; Edward Karpman, MD & Jesse Mills, MD
03:00 p.m. - 03:30 p.m.
Location: Broadway Ballroom F
6th Annual Robert Krane Lecture
Moderator: Alexander Pastuszak, MD, PhD
03:00 p.m. - 03:30 p.m.
Novel Strategies for Cavernous Nerve Regeneration Following Radical Prostatectomy
Speaker: Kelvin Davies, BSc, MSc, PhD
03:30 p.m. - 04:00 p.m.
Location: Broadway Ballroom G-K
Coffee Break
03:35 p.m. - 04:00 p.m.
Location: Broadway Ballroom Foyer - E-poster Station 1
E-poster Session 13 - Erectile Dysfunction Surgical 4
Moderator: Matthew Pollard, MD
03:35 p.m. - 03:38 p.m.
The Use of Oxidized Cellulose and Fibrin Sealant to Prevent Infection Following Penile Prosthesis Insertion (#396)
Speaker: Meenakshi Davuluri
03:38 p.m. - 03:41 p.m.
Modern IPP Exchange Techniques are Safe and Effective (#397)
Speaker: Madeleine Manka
03:41 p.m. - 03:44 p.m.
The Cost of Erections After PDEI Failure - A Long-term Cost Analysis of Penile Prosthesis versus Intracavernosal Injection (#398)
Speaker: Fernandino Vilson
03:44 p.m. - 03:47 p.m.
Impact of Key Pinch Strength on Preference for Commonly Available Inflatable Penile Prostheses: A Prospective Study Analyzing Both Inflation and Deflation (#399)
Speaker: Jordan Best
03:47 p.m. - 03:50 p.m.
Inflatable Penile Prostheses in Solid Organ Transplant Recipients: Longitudinal Results (#400)
Speaker: Brian Dick
03:50 p.m. - 03:53 p.m.
Penile Prosthesis Placement in Patients with Corporal Fibrosis Secondary to Infection or Priapism: Outcomes and Complications (#401)
Speaker: Priyanka Bearelly
03:53 p.m. - 03:56 p.m.
Comparison of Intraoperative Cultures in Patients Undergoing Removal/Replacement of a Non-infected Penile Prosthesis Followed by Subsequent Salvage or Explantation (#402)
Speaker: Jason Chandrapal
03:56 p.m. - 03:59 p.m.
Low Pre-operative Serum Testosterone Does Not Increase Rate of Complication Following Inflatable Penile Prosthesis Insertion (#403)
Speaker: Matthew Hudnall
03:35 p.m. - 04:00 p.m.
Location: Broadway Ballroom Foyer - E-poster Station 2
E-poster Session 14 - Miscellaneous 2
Moderator: Paul Gittens, MD
03:35 p.m. - 03:38 p.m.
A Qualitative Analysis of Internet Forum Discussions on Hard Flaccid Syndrome (#404)
Speaker: Mohamad M. Osman
03:38 p.m. - 03:41 p.m.
Preoperative Analgesia Does Not Alter Subjective Pain Assessment in Men Undergoing Vasectomy: An Early Prospective Study (#405)
Speaker: Jacob Jipp
03:41 p.m. - 03:44 p.m.
Diversity in Reproductive Health and Human Sexuality: Assessing Attitudes Comfort and Knowledge in Learners Before and After a Pilot Curriculum (#406)
Speakers: Rachel Friedlander & Sophie Mou
03:44 p.m. - 03:47 p.m.
Google Search Trends for Topics in Men's Health (#407)
Speaker: Karim Hanna
03:47 p.m. - 03:50 p.m.
Effect of Low-dose PDE5i and Low-energy Shock Wave on Acute Phase of Peyronie's Disease (#408)
Speaker: Mujun Lu
03:50 p.m. - 03:53 p.m.
Evaluation of the Prevalence and Grading of Calcified Plaques Among Men with Peyronie's Disease: A Prospective Analysis (#409)
Speaker: Thomas Masterson, MD
03:59 p.m. - 04:02 p.m.
Penoscrotal Ring Entrapment: A Case Report and Literature Review of Techniques Aimed at Reduction of Iatrogenic Injury (#358)
Speaker: Eric Webb
04:00 p.m. - 05:30 p.m.
Location: Broadway Ballroom F
Emerging Treatments for ED and PD
Moderators: Seth Cohen, MD, MPH & Hossein Sadeghi-Nejad, MD, FACS
04:00 p.m. - 04:15 p.m.
Platelet Rich Plasma - Whats the Evidence for Efficacy in ED / PD
Speaker: Serge Carrier, MD, FRCS(C), MMgmt
04:15 p.m. - 04:30 p.m.
Stem Cell Therapies in Management of ED and PD
Speaker: Trinity Bivalacqua, MD, PhD
04:30 p.m. - 04:40 p.m.
Establishing the Safety Profile in Sexual Partners of a New Topical Nitroglycerin Gel for the Treatment of Erectile Dysfunction (#031)
Speaker: Tim Holland
04:40 p.m. - 04:50 p.m.
Stem Cell Therapy for the Treatment of Erectile Dysfunction and Peyronie’s Disease: A Survey of Stem Cell Clinics Across the USA (#032)
Speaker: Jordan Best
04:50 p.m. - 05:00 p.m.
Programmable Electrically-Stimulated Penile Erection: a Chronic Study on Baboons (#033)
Speaker: Vadim Mitrokhin
05:00 p.m. - 05:15 p.m.
LI-SWT for ED and PD Basic Mechanisms and Clinical Effects
Speaker: Alan Shindel, MD
05:15 p.m. - 05:30 p.m.
Debate Emerging Treatments Should be Offered to Men with PD and ED
Speakers: Nelson Bennett, MD, FACS & Gregory Broderick, MD
04:00 p.m. - 05:30 p.m.
Location: Broadway Ballroom C-D
Female Sexual Dysfunction - Moderated Posters
Moderators: Sherita King, MD & Ashley Winter, MD
04:15 p.m. - 04:20 p.m.
Predictors of Response to Low Dose Estradiol Vaginal Inserts for Moderate to Severe Dyspareunia (#190)
Speaker: Irwin Goldstein, MD
04:20 p.m. - 04:25 p.m.
Comparing Provider-Led Sexual Health Counseling of Male and Female Radical Cystectomy Patients (#191)
Speaker: Natasha Gupta
04:25 p.m. - 04:30 p.m.
Flibanserin: Enhanced Pharmacovigilance Study to Assess and Analyze the Risks of Adverse Events of Special Interest (#192)
Speaker: Leah Millheiser
04:30 p.m. - 04:35 p.m.
Bremelanotide for Hypoactive Sexual Desire Disorder: Contraceptive Subgroups Efficacy Analysis (#193)
Speaker: Anita Clayton
04:35 p.m. - 04:40 p.m.
Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies (#194)
Speaker: James Simon, MD, CCD, NCMP, IF, FACOG
04:40 p.m. - 04:45 p.m.
Retrospective Chart Review of Treatment Outcome Following Low-Intensity Shockwave Therapy for the Treatment of Vestibulodynia with Urogold 100™ (#195)
Speaker: Jessica Yih, MD
04:45 p.m. - 04:50 p.m.
Optimizing Sexual Satisfaction for Women With Spina Bifida: A Qualitative Study (#196)
Speaker: Courtney Streur
04:50 p.m. - 04:55 p.m.
A Double-blind, Placebo-controlled, 2-Way Crossover Study Using Thermography to Assess the Pharmacodynamics of Sildenafil Cream, 3.6% in Healthy Women (#197)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE
04:55 p.m. - 05:00 p.m.
Associations Between Domains of Urinary Symptoms and Female Sexual Dysfunction in Women with Type 1 Diabetes (#198)
Speaker: Cody Gibbons
05:00 p.m. - 05:05 p.m.
Attitude of Women Nurses for Embarrassing Female Sexual and Urinary Symptoms in Korea (#199)
Speaker: Kweonsik Min
05:05 p.m. - 05:10 p.m.
Female Genital Self-image in Women With and Without Female Genital Mutilation/Cutting in Jeddah, Saudi Arabia (#200)
Speaker: Abdulrahim Rouzi
05:10 p.m. - 05:15 p.m.
"It sounds like you're a piece of an engine in a car": SGM Women's Perception of the Female Sexual Function Index - A Qualitative Interview Study (#202)
Speaker: Tiffany Le
04:00 p.m. - 05:30 p.m.
Location: Broadway Ballroom A-B
Sexual Dysfunction in Gay Populations
Moderators: Brian Christine, MD & Joshua Gonzalez, MD
04:00 p.m. - 04:15 p.m.
Sexual Dysfunction in Gay Males
Speaker: Philip Cheng, MD
04:15 p.m. - 04:30 p.m.
Sexual Dysfunction in Lesbian Women
Speaker: Tami Rowen, MD, MS, FACOG
04:30 p.m. - 04:45 p.m.
ED in Gay Men: What Do I Need to Consider?
Speaker: Joshua Gonzalez, MD
04:45 p.m. - 05:00 p.m.
HIV and Sexual Dysfunction in the Gay Male
Speaker: David Latini, PhD
05:00 p.m. - 05:20 p.m.
Panel Discussion - What is Unique About Sexual Dysfunction in Gay Male and Female Populations and How Do I Address This as a Clinician?
Speakers: Philip Cheng, MD; Joshua Gonzalez, MD; Erika Kelley, PhD; David Latini, PhD & Tami Rowen, MD, MS, FACOG
05:20 p.m. - 05:30 p.m.
Q&A
05:30 p.m. - 06:30 p.m.
Location: Broadway Ballroom F
Residents Arena
Moderators: Jonathan Beilan, MD; Thomas Masterson, MD; Alexander Tatem, MD & Nannan Thirumavalavan, MD
05:30 p.m. - 05:45 p.m.
The ABU and The Making of an Exam
Speaker: Hossein Sadeghi-Nejad, MD, FACS, ABU Exam Committee
05:45 p.m. - 05:49 p.m.
Validation of a Full-Immersion Simulation Penile Prosthesis Model Using Three-dimensional Printing and Hydrogel Molding Technology (#034)
Speaker: Michael Witthaus
05:49 p.m. - 05:53 p.m.
Inflatable Penile Prosthesis Adverse Events: Comparison of the Alternative Summary Report (ASR) and Manufacturer and User Facility Device Experience (MAUDE) Databases (#035)
Speaker: Daniel Rabinowitz
05:53 p.m. - 05:57 p.m.
A Trial of Low-Intensity Shockwave Therapy for Penile Rehabilitation After Radical Prostatectomy (#036)
Speaker: Kyle Ericson
05:57 p.m. - 06:01 p.m.
Preoperative Urine Culture and its Affect on Penile Prosthesis Infection (#037)
Speaker: Steven Lomax
06:01 p.m. - 06:05 p.m.
What is the Venous Drainage of the Penis After Radical Prostatectomy? An Observational Study Using CT Cavernosography (#038)
Speaker: James Trussler
06:05 p.m. - 06:09 p.m.
Subcutaneous Heparin at Time of Inflatable Penile Prosthesis Surgery Does Not Increase Postoperative Hematoma Rate (#039)
Speaker: Kevin Hebert
06:09 p.m. - 06:13 p.m.
Continuation of Baseline Antithrombotic Therapy in Men Undergoing Inflatable Penile Prosthesis Surgery: An Update on Outcomes (#040)
Speaker: Kevin Hebert
06:13 p.m. - 06:17 p.m.
Does Prostate Biopsy Cause Erectile Dysfunction? A Systematic Review of the Literature and Meta-Analysis (#041)
Speaker: Christopher Gaffney
06:17 p.m. - 06:21 p.m.
Predictors of Early Response to Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction (#042)
Speaker: Daniel Roberson
06:21 p.m. - 06:25 p.m.
Relationship Between Endogenous Testosterone and Lipid Parameters: Insight from REDUCE Study Group Database (#043)
Speaker: Kelly Harris
06:25 p.m. - 06:29 p.m.
Short-acting Exogenous Testosterone Appears to have a Lesser Effect on Gonadotropins Compared to Long-acting Testosterone: A Pilot Study Using Mouse Models (#044)
Speaker: Kevin Chu
Evening
Sunday, October 27, 2019
Morning
07:45 a.m. - 08:00 a.m.
Location: Broadway Ballroom F
Breakfast
08:00 a.m. - 09:45 a.m.
Location: Broadway Ballroom F
Take Home Messages (including breakfast)
Moderator: Alexander Pastuszak, MD, PhD
08:00 a.m. - 08:15 a.m.
Basic Science
Speaker: Benjamin Christensen, PhD
08:15 a.m. - 08:30 a.m.
Female Sexual Medicine
Speaker: Jessica Yih, MD
08:30 a.m. - 08:45 a.m.
Erectile Dysfunction
Speaker: Chirag Dave, MD
08:45 a.m. - 09:00 a.m.
Peyronies, Androgens, and Other Sexual Dysfunction
Speaker: Jason Akerman, MD
09:00 a.m. - 09:15 a.m.
BPH / Incontinence
Speaker: Brittani Barrett-Harlow, MD
09:15 a.m. - 09:30 a.m.
Gay / Transgender
Speaker: Philip Cheng, MD
09:45 a.m. - 10:00 a.m.
Location: Broadway Ballroom F
Awards and Closing
Afternoon

Our Services

About SMSNA

Established in 1994, our objective has been to promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of the anatomy, physiology, pathophysiology, diagnosis, and treatment...

~ Read More

Contact Us

SMSNA Executive Office
c/o Status Plus
+1 (952) 683 1917
+1 (952) 314 8212
info@smsna.org

Address
14305 Southcross Dr
Suite 100
Burnsville, MN 55306